Valspar (VAL) was upgraded at Robert Baird to outperform from neutral. Twelve-month price target is $80. Legacy business appears to be stabilizing, Robert Baird said.

Williams-Sonoma (WSM) was upgraded at Argus to buy from hold. Twelve-month price target is $68. Company is growing its online business, Argus said.

Exxon Mobil (XOM) was downgraded at Citigroup. Valuation call, based on a 12-month price target of $108, Citigroup said.

Yum Brands (YUM) was downgraded at Morgan Stanley to equal-weight. Twelve-month price target is $77. China concerns should continue to hang over the stock, Morgan Stanley said.

Stock Comments / EPS Changes

Merck (MRK) price target, EPS estimates were increased at Jefferies. Underappreciated restructuring potential, Jefferies said. Twelve-month price target is $54. Hold rating.

Pfizer (PFE) price target, EPS were increased at Jefferies. Data-flow and potential approvals in the anticancer and HCV space are the most significant clinical catalysts. Jefferies said. Twelve-month price target is $33. Hold rating.

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

If you liked this article you might like

Avery Dennison's Long-Running Uptrend Isn't Over

Cramer: Top 10 Reasons Why the Bull Market Is Mistrusted

You Should Be Worried: Cramer's 'Mad Money' Recap (Thursday 7/6/17)

Avery Dennison: Avoid a Potential Sticky Situation